What Poseida Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Yarema Kristin | President and CEO | Jan 08 | Tender Offer · U | −615,836 | — | — | 0 |
| Schmid John P. | Director | Jan 08 | Tender Offer · U | −58,950 | — | — | 0 |
| Collins Cynthia | Director | Jan 08 | Tender Offer · U | −58,950 | — | — | 0 |
| Baum Charles M | Director | Jan 08 | Tender Offer · U | −78,600 | — | — | 0 |
| Amado Rafael | Director | Jan 08 | Tender Offer · U | −58,950 | — | — | 0 |
| Gergen Mark J | President and CEO | Jan 08 | Tender Offer · U | −636,726 | — | — | 0 |
| Leonhardt Harry J | GC & Chief Compliance Officer | Jan 08 | Tender Offer · U | −223,640 | — | — | 0 |
| Lloyd Marcea Bland | Director | Jan 08 | Tender Offer · U | −68,950 | — | — | 0 |
| Rizvi Syed Ali-aamir | Chief Medical Officer | Jan 08 | Tender Offer · U | −185,000 | — | — | 0 |
| Mylet Johanna | Chief Financial Officer | Jan 08 | Tender Offer · U | −254,852 | — | — | 0 |
| Corning Luke | Director | Jan 08 | Tender Offer · U | −58,950 | — | — | 0 |
| Malin Life Sciences Holdings Ltd | 10% owner | Jan 08 | Tender Offer · U | −11,835,673 | — | — | 0 |
| Gergen Mark J | Executive Chairman | Jan 02 | Withheld — tax / exercise cost · F | −23,313 | $9.60 | −$224K | 630,726 |
| Gergen Mark J | Executive Chairman | Dec 10 | Open-market sale · S | −30,000 | $9.46 | −$284K | 651,291 |
| Gergen Mark J | Executive Chairman | Dec 10 | Exercise / conversion · M | +30,000 | $2.78 | +$83.4K | 681,291 |
| Gergen Mark J | Executive Chairman | Nov 26 | Open-market sale · S | −30,000 | $9.27 | −$278K | 651,291 |
| Gergen Mark J | Executive Chairman | Nov 26 | Exercise / conversion · M | +30,000 | $2.78 | +$83.4K | 681,291 |
| Baum Charles M | Director | Jun 17 | Grant / award · A | +19,650 | — | — | 78,600 |
| Collins Cynthia | Director | Jun 17 | Grant / award · A | +19,650 | — | — | 58,950 |
| Schmid John P. | Director | Jun 17 | Grant / award · A | +19,650 | — | — | 58,950 |
Loading...
